ACTIV-6: COVID-19 Study of Repurposed Medications - Arm A (Ivermectin 400)

NCT05736861 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1800
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Susanna Naggie, MD

Collaborators